The Cell Surgical Network is proud to have published one of the largest safety data paper on the use of autologous stromal vascular fraction (SVF) to date, including intravenous infusions. This paper comes from the work of many of our founding members, their dedication to our institutional review board approved processes, and their work in tracking patient outcomes through our network wide database. While the Cell Surgical Network aims to provide our patients the most personalized cellular medical care available, we needed to demonstrate that the surgery we practice is first and foremost safe. We continue to make many advances in our investigational work, aggregating patient data and outcomes network-wide, consistently advancing cellular medicine along the way.

CSN Safety Data Paper
SVF and Shock Wave for Erectile Dysfunction
Ratio of ADSC to HSC to Predict Outcomes
SVF Review
SVF For Chronic Pain
SVF and Shockwave Therapy
SVF for TBI Laboratory Study
Delivery of oncolytic vaccinia virus
SVF and Intracerebroventricular Injections for Neurodegenerative Disorders
First‑in‑human study of TK‑positive oncolytic vaccinia virus delivered by SVF
First‑in‑human study of TK‑positive oncolytic vaccinia virus delivered by SVF
SVF for Interstitial Cystitis
SVF for Knee Osteoarthritis